Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection

NCT05122754 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: B/F/TAF
DRUG: TDF-based triple ART regimen switching to B/F/TAF

Sponsor

Shanghai Public Health Clinical Center

Collaborators

[object Object]
[object Object]